Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism
- Conditions
- Hypoparathyroidism PostproceduralQuality of Life
- Interventions
- Other: Empiric use of Calcium Carbonate and CalcitriolOther: PTH based Calcium Carbonate and Calcitriol repletion
- Registration Number
- NCT03249012
- Lead Sponsor
- CHU de Quebec-Universite Laval
- Brief Summary
This study aims to compare two different protocols commonly used in the management of post thyroidectomy hypoparathyroidism : PTH based calcium repletion and empiric repletion. The investigators aim to compare the quality of life associated with these two protocols in a randomized trial.
- Detailed Description
Enrolled patients will be randomized in two treatment groups. In group 1, all patients will receive calcium carbonate and calcitriol in the post-operative period, with standardized weaning. In group 2, patients will be prescribed calcium carbonate and calcitriol only if their post-operative PTH dosage is 25% or less of the pre-operative dosage, or if post-operative PTH is inferior to 15.
The Short-Form 36 (SF-36) questionnaire (French canadian version) will be used to assess quality of life pre-operatively and at post-op week 1 and 4. Symptoms of hypocalcemia and adverse effects of calcium carbonate and calcitriol will be monitored at week 1 and 4.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 120
- Total thyroidectomy or completion hemithyroidectomy
- Need for neck dissection
- Unable to fill in questionnaires (intellectual deficit, severe psychiatric disorder, illiterate, does not speak French or English)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Empiric calcium and calcitriol repletion group Empiric use of Calcium Carbonate and Calcitriol All patients in this group will receive post-operative calcium carbonate and calcitriol. PTH based repletion group PTH based Calcium Carbonate and Calcitriol repletion Patients in this group will be prescribed calcium carbonate and calcitriol based on their post-operative PTH.
- Primary Outcome Measures
Name Time Method Change from baseline quality of life at 1 and 4 weeks Pre-op, 1 week post-op and 4 weeks post-op Short Form 36 (SF-36) questionnaire
- Secondary Outcome Measures
Name Time Method Occurence and change in pharmacologic adverse effects of calcium carbonate and calcitriol 1 week post-op, 4 weeks post-op A questionnaire about the adverse effects of calcium carbonate and calcitriol will be completed at post-op week 1 and 4
Occurence and change in symptoms of hypocalcemia 1 week post-op, 4 weeks post-op A questionnaire about symptoms of hypocalcemia will be completed at post-op week 1 and 4.
Trial Locations
- Locations (1)
CHU de Quebec
🇨🇦Québec, Quebec, Canada